We are live on ! Find out more
RBOT

Vicarious Surgical

Delisted

RBOT was delisted on the 2nd of March, 2026.

74 hedge funds and large institutions have $86.1M invested in Vicarious Surgical in 2023 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 30 increasing their positions, 12 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

608% more call options, than puts

Call options by funds: $92K | Put options by funds: $13K

150% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 12

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

0.03% more ownership

Funds ownership: 1.45%1.48% (+0.03%)

6% less funds holding

Funds holding: 7974 (-5)

15% less capital invested

Capital invested by funds: $102M → $86.1M (-$15.8M)

29% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 14

Holders
74
Holders Change
-5
Holders Change %
-6.33%
% of All Funds
1.16%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
10
Increased
30
Reduced
12
Closed
14
Calls
$92K
Puts
$13K
Net Calls
+$79K
Net Calls Change
-$65K

RBOT Hedge Fund Activity: Q2 2023 in Review

74 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Vicarious Surgical (RBOT) for Q2 2023, worth a combined $86.1M — down 15% from $102M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of RBOT and 10 opened new positions — a net loss of 4 holders — while 12 trimmed existing stakes and 30 added.

The largest buyer was BlackRock, adding an estimated $1.94M. The largest seller was Marshall Wace, cutting an estimated $304K.

  • 74 institutional investors held Vicarious Surgical (RBOT) as of Q2 2023, down from 79 in Q1 2023.
  • Funds reported $86.1M of Vicarious Surgical stock for Q2 2023, down 15% quarter-over-quarter.
  • 10 funds opened new Vicarious Surgical positions in Q2 2023 and 14 closed out, a net change of -4 holders.
  • The largest Vicarious Surgical buyer in Q2 2023 was BlackRock, an estimated $1.94M added.
  • The largest Vicarious Surgical seller in Q2 2023 was Marshall Wace, an estimated $304K sold.

Based on aggregated 13F filings for Q2 2023.